Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes.
Phase of Trial: Phase III
Latest Information Update: 20 Nov 2011
At a glance
- Drugs Glimepiride (Primary) ; Pioglitazone (Primary) ; Voglibose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Nov 2011 Last checked against ISRCTN: Current Controlled Trials record.
- 26 Sep 2007 The expected completion date for this trial is now 31 Dec 2006.
- 24 Sep 2007 New trial record.